Cargando…
A novel outpatient desensitization protocol for recombinant human erythropoietin allergy in a pediatric patient
BACKGROUND: Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desensitization are rare. CASE PRESENTATION: We report here a novel epoetin alfa outp...
Autores principales: | Rosa, Jaime S., Vuong, Van B., Haskin, Orly, Liu, Anne Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846227/ https://www.ncbi.nlm.nih.gov/pubmed/29545827 http://dx.doi.org/10.1186/s13223-018-0233-1 |
Ejemplares similares
-
Drug allergy: Causes and desensitization
por: Warrington, Richard
Publicado: (2012) -
A desensitization protocol for delayed allergy to cytarabine: analysis of two cases
por: Albanesi, Marcello, et al.
Publicado: (2018) -
The first successful desensitization protocol in exenatide allergy: a case report
por: Yeğit, Osman Ozan, et al.
Publicado: (2023) -
ASA Allergy and Desensitization Protocols in the Management of CAD: A Review of Literature
por: Verdoia, Monica, et al.
Publicado: (2023) -
Safety and efficacy of a sublingual-oral desensitization protocol in cow’s milk allergy treatment
por: Piedade, S, et al.
Publicado: (2013)